Navigation Links
BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/17/2009

uth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements regarding the Company's competitive advantages, the impact of changes in China's healthcare industry on the Company's growth, the Company's expected financial performance in 2009 and the Company's expectations for each of its business units in 2009. These statements are subject to uncertainties and risks including, but not limited to, operating performance, general financial, economic, and political conditions affecting the biotechnology and pharmaceutical industries and the Chinese pharmaceutical market, the ability to timely manufacture and distribute the Company's products and other risks contained in reports filed by the Company with the Securities and Exchange Commission. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.



                    BMP Sunstone Corporation and Subsidiaries
             Non GAAP Condensed Consolidated Statements of Operation
                ($ amounts, except per share amounts in thousands)

                                           For the Three      For the Twelve
                                            months ended       months ended
                                            December 31,       December 31,
                                           2008     2007      2008      2007

    Revenues:
     Third parties       
'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. BMP Sunstone to Present at UBS Global Healthcare Services Conference
2. BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
3. BMP Sunstone Receives High Tech Status
4. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
5. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
6. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
7. BMP Sunstone Reports Third Quarter 2008 Financial Results
8. BMP Sunstone Announces Participation in November Investor Conferences
9. BMP Sunstone Announces Participation in September Investor Conference
10. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
11. BMP Sunstone Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... as a finalist in the International Bio 2009 Convention Contest, "Be ... ... April 7, 2009 -- Impact Systems Inc., ( www.ImpactSystems.com ), a ... today announced their Compliance-in-a-Box video has been selected as a finalist ...
... NORTH BRUNSWICK, N.J., April 7 WellGen, Inc. today ... been appointed President and Chief Executive Officer. ... who was serving as interim Chief Executive Officer. ... and as President and Chief Financial Officer of Amphion ...
... Full Control of the Entire Clinical Trial Registration ... while Adhering to Changing Regulatory Requirements; Two Top-Ten ... Trial Registration and Results Disclosure ProcessesNEW YORK, April ... ), a leading services firm that ...
Cached Biology Technology:Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist 2Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist 3Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 2Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 3Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 2Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 3Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 4
(Date:4/23/2014)... Valley, NY. (Apr. 23, 2014) People who have ... potential to restore neurological function. However, a study conducted ... issue of Cell Transplantation , but is currently ... http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1168Chen , has found that when one group ... cells (PBSCs) injected directly into the brain and a ...
(Date:4/23/2014)... transformed the energy landscape in the U.S., but ... among the energy industry, residents and agricultural interests ... that degraded water quality is a potential risk ... appears in the ACS journal Environmental Science ... colleagues point out that a major criticism of ...
(Date:4/23/2014)... coined term for novels and films which focus on the ... shows how these fictions serve as a mental laboratory that ... and imagine other living conditions. , "Global warming is ... it is also a cultural phenomenon in which meaning is ... we see. And there are so many of them now ...
Breaking Biology News(10 mins):Autologous stem cell therapy improves motor function in chronic stroke victims 2How to avoid water wars between 'fracking' industry and residents 2Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3
... for Microbiology (ASM) Abbott Laboratories Award in Clinical ... Shearer, Ph.D., Chief, Cell Mediated Immunity Section, Experimental ... Health (NIH), Bethesda, MD, for his research on ... this award recognizes a distinguished scientist in clinical ...
... PhD, associate professor of chemistry at New Jersey ... awarded a patent today for a novel composition ... Perfluoro-Phthalocyanine Compounds" (US Patent Number 7,670,684) discloses a ... materials are comprised of organic scaffolds with metal ...
... one of the world,s most widely used pesticides, wreaks ... emasculating three-quarters of them and turning one in 10 ... of California, Berkeley, biologists. The 75 percent that ... inability to reproduce in the wild, reports UC Berkeley,s ...
Cached Biology News:American Society for Microbiology honors Gene M. Shearer 2NJIT researcher awarded patent for hydrophobic, corrosion-resistant coating 2Pesticide atrazine can turn male frogs into females 2Pesticide atrazine can turn male frogs into females 3Pesticide atrazine can turn male frogs into females 4
Request Info...
"BioTracker 6X Bromophenol Blue Tracking Dye is composed of 60% St DI H2O, 30% Glycerol, 10% 10XTE, 0.25% BPB Dye and 0.85% SDS....
Agarose, low melting/gelling temperature, high MW separation (>1000 bp), 25 g. Suitable for enzymatic modifications. Nuclease-free.Gel point: 24-30 C, EEO (-mr): 300 gm/cm2. Category: Nucleotides &...
Request Info...
Biology Products: